Found this reading WGs thread and liked the chart and PRs coming out on it and operates in two segments BioTherapeutics and BioDefense with products in trials,,,Orbec an orally administered corticosteroid that exerts a potent and local anti-inflammatory effect in the mucosal tissue of the gastrointestinal tract;Oraprine, an oral suspension of azathioprine; and LPE and PLP systems for delivery of water-insoluble drugs The BioDefense segment offers RiVax, ricin toxin vaccine, a heat stable toxin that is isolated and purified from the bean of the castor plant; and BT-VACC, the Botulinum toxin, a poisonous natural substance that causes acute, symmetric, and descending flaccid paralysis due to its action on peripheral cholinergic nerves. I bought this stock when it was trading @.26 What better risk/reward can you have then this.

Another I give credit to WG for. This stock has so much potential I had to grab some when it was @.395 a while back and even though it has gone down since and has just about come back to my buy point I'll contiue to hold for the PR on dupont. Another I think Reward far outweighs Risk and will continue to hold

Just bought this one a few days ago @10.04 . It's been trading sideways for 5 months now and just came back above 21 DMA If trend continues as the past five months I should get limit sell order filled @11.00 within one month Wish me goodluck

Just a gamble here for a buyout. Bought @8.025 a few days ago The form the bailout might take is unclear, but sources believe that Mass Mutual, which operates as a closed-end investment company, may make an investment in Kansas City, Mo.-based NovaStar. The investment could be made either directly or via an affiliate such as Babson Capital Management, which is itself an investment company and serves as adviser to Mass Mutual.